Insider · CIK 0001785107
Nicholas A Yacobozzi
officer
Files at MTUS (Metallus Inc.). First filing Jul 23, 2025, latest Jul 23, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $396k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MTUS: Metallus Inc.
MTUSOct 9, 2026 · close 19.99
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | Metallus Inc. | $396k 21,974 shares | -31% | +55% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 1, 2026 | MTUS Metallus Inc. | FTax withholding Common Stock | -2,842 | $17.00 | $48k | 47,543 | Mar 2, 2026 |
| Mar 2, 2026 | MTUS Metallus Inc. | AGrant or award Common Stock | +6,500 | $0.00 | $0 | 54,043 | Mar 2, 2026 |
| Feb 11, 2026 | MTUS Metallus Inc. | AGrant or award Common Stock | +3,032 | $0.00 | $0 | 51,921 | Feb 12, 2026 |
| Feb 11, 2026 | MTUS Metallus Inc. | FTax withholding Common Stock | -1,536 | $21.51 | $33k | 50,385 | Feb 12, 2026 |
| Jul 23, 2025 | MTUS Metallus Inc. | SOpen-market sale Common Stock10b5-1 | -21,974 | $18.00 | $396k | 48,889 | Jul 23, 2025 |
| May 19, 2025 | MTUS Metallus Inc. | AGrant or award Common Stock | +22,520 | $0.00 | $0 | 70,863 | May 20, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.